CTRI/2025/01/079100 [Registered on: 21/01/2025] Trial Registered Prospectively
Last Modified On:
13/08/2026
Post Graduate Thesis
Yes
Type of Trial
Interventional
Type of Study
Ayurveda
Study Design
Single Arm Study
Public Title of Study
Panchakarma treatment in paralysis.
Scientific Title of Study
A clinical study on effectiveness of Panchakarma along with samana in cikitsa in Paksaghata w.s.r to Hemiplegia
Trial Acronym
nil
Secondary IDs if Any
Secondary ID
Identifier
NIL
NIL
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Name
Dr Rutvaben B Amaliyar
Designation
P G Scholar ( Panchakarma)
Affiliation
J S Ayurveda Mahavidyalaya, Nadiad
Address
Department of Panchakarma, J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital, Nadiad, Kheda.
Kheda GUJARAT 387001 India
Phone
7567457269
Fax
Email
rutvabhimjibhai@gmail.com
Details of Contact Person Scientific Query
Name
Dr Jaimin R Patel
Designation
Professor of Department of Panchakarma
Affiliation
J S Ayurveda Mahavidyalaya, Nadiad
Address
Department of Panchakarma, J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital, Nadiad, Kheda.
Kheda GUJARAT 387001 India
Phone
9427859535
Fax
Email
vd.jaimin@gmail.com
Details of Contact Person Public Query
Name
Dr Jaimin R Patel
Designation
Professor of Department of Panchakarma
Affiliation
J S Ayurveda Mahavidyalaya, Nadiad
Address
Department of Panchakarma, J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital, Nadiad, Kheda.
Kheda GUJARAT 387001 India
Phone
9427859535
Fax
Email
vd.jaimin@gmail.com
Source of Monetary or Material Support
Sundar Ayurved teaching pharmacy of J S Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital, college road, Nadiad, Kheda, Gujarat. 387001
Primary Sponsor
Name
J S Ayurveda Mahavidyalaya
Address
Department of Panchakarma, J S Ayurveda Mahavidyalaya, college road, Nadiad -387001
Type of Sponsor
Private medical college
Details of Secondary Sponsor
Name
Address
NIL
NIL
Countries of Recruitment
India
Sites of Study
No of Sites = 1
Name of Principal
Investigator
Name of Site
Site Address
Phone/Fax/Email
Dr Rutvaben B Amaliyar
P D Patel Ayurveda Hospital
Department of Panchakarma, J S Ayurveda MahaVidhyalaya, College road, Nadiad 387001 Kheda GUJARAT
7567457269
rutvabhimjibhai@gmail.com
Details of Ethics Committee
No of Ethics Committees= 1
Name of Committee
Approval Status
INSTITUTIONAL ETHICS COMMITTEE, MAM UNIVERSITY-NADIAD
Approved
Regulatory Clearance Status from DCGI
Status
Not Applicable
Health Condition / Problems Studied
Health Type
Condition
Patients
(1) ICD-10 Condition:G00-G99||Diseases of the nervous system. Ayurveda Condition: PAKSHAGHATA/PAKSHAVADHAH,
Intervention / Comparator Agent
sno
Intervention/Comparator
Type
Drug-Type
Procedure Name
Details
1
Intervention Arm
Procedure
-
aBya~ggaH, अभ्यंग
(Procedure Reference: charak samhita, Procedure details: sarvanga abhyanga with atibala taila will be done in the morning) (1) Medicine Name: atibala, Reference: bhavprakash nighantu, Route: Topical, Dosage Form: Taila, Dose: 50(ml), Frequency: od, Duration: 34 Days
2
Intervention Arm
Procedure
-
svedanam, स्वेदनम्
(Procedure Reference: charak samhita, Procedure details: after abhyanga ,sarvanga baspa svedana will be given to patient in morning) (1) Medicine Name: nirgundi patra, Reference: bhavprakash nighantu, Route: Topical, Dosage Form: Kalka/ Paste, Dose: 100(g), Frequency: od, Duration: 34 Days
3
Intervention Arm
Procedure
-
virecana-karma, विरेचन-कर्म
(Procedure Reference: charak samhita, Procedure details: on 3rd day of sarvanga abhyanga & svedan,virecana will be done in morning) (1) Medicine Name: dindayal churna, Reference: bhaishajya sara sangraha, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Duration: 1 Days(2) Medicine Name: eranda sneha, Reference: bhaishajyasara sangraha, Route: Oral, Dosage Form: Taila, Dose: 50(ml), Frequency: od, Duration: 1 Days
4
Intervention Arm
Procedure
-
SirobastiH, शिरोबस्तिः
(Procedure Reference: ashtang hridaya, Procedure details: after shodhana karma shirobasti will be done in afternoon.) (1) Medicine Name: atibala taila, Reference: Bhavprakash niganthu, Route: Topical, Dosage Form: Taila, Dose: 400(ml), Frequency: od, Duration: 30 Days
5
Intervention Arm
Procedure
-
nasyam/ nastam, नस्यम्/ नस्तम्
(Procedure Reference: astanga hridaya, Procedure details: after shodhana karma from next day nasya karma will be done with Atibala Taila (8-8drops each nostril)) (1) Medicine Name: Atibala taila, Reference: bhavprakash niganthu, Route: Nasal, Dosage Form: Taila, Dose: 2(ml), Frequency: od, Duration: 30 Days
6
Intervention Arm
Procedure
-
bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म
(Procedure Reference: charaka samhita, Procedure details: After virecana karma niruha basti will be given to patient in morning.) (1) Medicine Name: dashamool kwatha, Reference: charak samhita, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 320(ml), Frequency: od, Duration: 1 Days
7
Intervention Arm
Procedure
-
bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म
(Procedure Reference: charak samhita, Procedure details: marta basti will bw given to pateint in the evening after food.) (1) Medicine Name: atibala taila, Reference: bhavprakash nigantu, Route: Rectal, Dosage Form: Taila, Dose: 40(ml), Frequency: od, Duration: 30 Days
Patients clinically examined and diagnosed with sign and symptoms of Paksaghata (Hemiplegia) and confirmed neurological examination.
Patients stable after the stroke condition and not chronic more than 5 years.
ExclusionCriteria
Details
Patients suffering from hemiplegia with severe systemic illnesses like uncontrilled diabetes mellitus, and/or any other associated comorbidity.
Patient contraindicated for Virechana, Basti, Nasya karma.
Method of Generating Random Sequence
Not Applicable
Method of Concealment
Not Applicable
Blinding/Masking
Open Label
Primary Outcome
Outcome
TimePoints
Improvement in the sign and symptoms along with score of FUGL-MAYER assessment of physical performance
Baseline, after discharge and follow up every week upto 4 week
Secondary Outcome
Outcome
TimePoints
nil
nil
Target Sample Size
Total Sample Size="30" Sample Size from India="30" Final Enrollment numbers achieved (Total)= "30" Final Enrollment numbers achieved (India)="30"